Diabetes drug found no better than placebo at treating nonalcoholic fatty liver disease

A randomised, double-blind, controlled trial of sitagliptin showed that the diabetes medication works no better than a pacebo in treating nonalcoholic fatty liver disease. Science Daily
Source: Society for Endocrinology - Category: Endocrinology Source Type: news